Application note: Explore cardiac function by measuring calcium oscillation or contraction patterns
Posted: 4 October 2019 | Molecular Devices | No comments yet
Understanding the impact of drugs on the cardiac system early in the development process is critical to improving the safety of drugs getting to market.
Cardiotoxicity is believed to be one of the primary causes of drug attrition during preclinical and clinical trials. In addition, environmental chemical exposure is a risk factor for cardiovascular disease, yet a number of environmental agents remain inadequately tested for their toxicological effects.
Here, Molecular Devices scientists demonstrate how you can record Ca2+ oscillation in 2D and 3D cardiomyocyte samples, analyze complex kinetic patterns, measure fluorescence over time and generate multi-parametric peak data using the ImageXpress Micro Confocal system.
Related content from this organisation
- Plasmids: Tackling Supply Chain and Manufacturing Challenges
- Machine Learning and AI in Enhancing Image Analysis of 3D Samples
- Transform your drug discovery pipeline with 3D cellular models
- Translating Promising Drug Candidates from Preclinical Screening to Clinical Trials
- Women in Stem with Vicky Marsh Durban
Related topics
Screening
Related organisations
Molecular Devices